-
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of "Buy" by Analysts
Источник: Buzz FX / 19 фев 2025 02:36:11 America/New_York
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Average Recommendation of "Buy" by Analysts Written by MarketBeat February 19, 2025 Share Link copied to clipboard. Shares of Tourmaline Bio, Inc. ( NASDAQ:TRML - Get Free Report ) have been assigned
Read more...